December 1, 2020 – Philadelphia, PA and Munich, Germany – ViGeneron, a gene therapy company, and WuXi Advanced Therapies Inc. (WuXi ATU), a leading Contract, Testing, Development and Manufacturing Organization (CTDMO), today announced a strategic partnership to...
The new laboratory will increase industry testing capacity for cell and gene therapies, enabling faster and more effective development, manufacturing and delivery to patients. November 18, 2020 – Philadelphia, PA – WuXi Advanced Therapies Inc. (WuXi ATU) –...
The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology CEOs of Asia for 2020. Asia’s healthtech market has continued its rapid growth with a select group of leaders and their companies standing out for their demonstrated operational...
October 19, 2020 – Philadelphia, PA – We are pleased to announce that Dr. Diya Ren will be joining WuXi Advanced Therapies Unit (WuXi ATU), as Executive Director of CMC, effective October 19, 2020. Dr. Ren brings extensive biopharma industry experience in...
October 5, 2020 – Philadelphia, PA – We are pleased to announce that Jennifer Cheung will be joining WuXi Advanced Therapies Unit (WuXi ATU), as Vice President of Quality Assurance and Regulatory Affairs effective October 5, 2020. Ms. Cheung brings a diverse...
SHANGHAI and PHILADELPHIA, June 1, 2020 — WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, announced today the appointment of Dr. David Chang as Chief Executive Officer of WuXi Advanced...
